2013

• Boyd, S., Mijatov, B., Pupo, G., Tran, S., Gowrishankar, K., Shaw, H., Goding, C., Scolyer, R., Mann, G., Kefford, R., Rizos, H., Becker, T. (2013), Oncogenic B-RAF(V600E) Signaling Induces the T-Box3 Transcriptional Repressor to Repress E-Cadherin and Enhance Melanoma Cell Invasion. The Journal of Investigative Dermatology. 133(5), 1269-1277. [Abstract]
• Mann, G., Pupo, G., Campain, A., Carter, C., Schramm, S., Pianova, S., Gerega, S., De Silva, C., Lai, K., Wilmott, J., Synnott, M., Hersey, P., Kefford, R., Thompson, J., Yang, Y., Scolyer, R. (2013), BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma. The Journal of Investigative Dermatology. 133(2), 509-517. [Abstract]

2012

• Kim, J., McCarthy, S., Thompson, J., Pupo, G., Vonthethoff, L., Nash, P., Mann, G., Scolyer, R. (2012), Cellular blue naevus involving the urinary bladder. Pathology. 44(7), 664-668. [Abstract]
• Cust, A., Goumas, C., Holland, E., Agha-Hamilton, C., Aitken, J., Armstrong, B., Giles, G., Kefford, R., Schmid, H., Hopper, J., Mann, G., Jenkins, M. (2012), MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study. International Journal of Cancer. 131(3), E269-281. [Abstract]
• Dutton-Regester, K., Aoude, L., Nancarrow, D., Stark, M., O'Connor, L., Lanagan, C., Pupo, G., Tembe, V., Carter, C., O'Rourke, M., Scolyer, R., Mann, G., Schmidt, C., Herington, A., Hayward, N. (2012), Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene. Genes, Chromosomes & Cancer. 51(5), 452-461. [Abstract]
• Dutton-Regester, K., Irwin, D., Hunt, P., Aoude, L., Tembe, V., Pupo, G., Lanagan, C., Carter, C., O'Connor, L., O'Rourke, M., Scolyer, R., Mann, G., Schmidt, C., Herington, A., Hayward, N. (2012), A high-throughput panel for identifying clinically relevant mutation profiles in melanoma. Molecular Cancer Therapeutics. 11(4), 888-897. [Abstract]
• Schramm, S., Campain, A., Scolyer, R., Yang, Y., Mann, G. (2012), Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis. The Journal of investigative dermatology. 132(2), 274-83. [Abstract]
• Law, M., Montgomery, G., Brown, K., Martin, N., Mann, G., Hayward, N., Macgregor, S. (2012), Meta-Analysis Combining New and Existing Data Sets Confirms that the TERT-CLPTM1L Locus Influences Melanoma Risk. Journal of Investigative Dermatology. 132(2), 485-487. [Abstract]
• Kasparian, N., Sansom-Daly, U., McDonald, R., Meiser, B., Butow, P., Mann, G. (2012), The nature and structure of psychological distress in people at high risk for melanoma: a factor analytic study. Psycho-Oncology. 21(8), 845-856. [Abstract]
• Howard, K., Salkeld, G., Mann, G., Patel, M., Cunich, M., Pignone, M. (2012), The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study. BMJ Open. 2(1), e000587. [Abstract]

2011

• Amos, C., Wang, L., Lee, J., Gershenwald, J., Chen, W., Fang, S., Kosoy, R., Zhang, M., Qureshi, A., Vattathil, S., Schacherer, C., Gardner, J., Wang, Y., Tim Bishop, D., Barrett, J., Macgregor, S., Hayward, N., Martin, N., Duffy, D., Mann, G., Cust, A., Hopper, J., Brown, K., Grimm, E., Xu, Y., Han, Y., Jing, K., McHugh, C., Laurie, C., Doheny, K., Pugh, E., Seldin, M., Han, J., Wei, Q. (2011), Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Human Molecular Genetics. 20(24), 5012-5023. [Abstract]
• Yokoyama, S., Woods, S., Boyle, G., Aoude, L., MacGregor, S., Zismann, V., Gartside, M., Cust, A., Haq, R., Harland, M., Taylor, J., Duffy, D., Holohan, K., Dutton-Regester, K., Palmer, J., Bonazzi, V., Stark, M., Symmons, J., Law, M., Schmidt, C., Lanagan, C., O'Connor, L., Holland, E., Schmid, H., Maskiell, J., Jetann, J., Ferguson, M., Jenkins, M., Kefford, R., Giles, G., Armstrong, B., Aitken, J., Hopper, J., Whiteman, D., Pharoah, P., Easton, D., Dunning, A., Newton-Bishop, J., Montgomery, G., Martin, N., Mann, G., Bishop, D., Tsao, H., Trent, J., Fisher, D., Hayward, N., Brown, K. (2011), A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature. 480(7375), 99-103. [Abstract]
• Scurr, L., McKenzie, H., Becker, T., Irvine, M., Lai, K., Mann, G., Scolyer, R., Kefford, R., Rizos, H. (2011), Selective Loss of Wild-Type p16(INK4a) Expression in Human Nevi. The Journal of Investigative Dermatology. 131(11), 2329-2332. [Abstract]
• Barrett, J., Iles, M., Harland, M., Taylor, J., Aitken, J., Andresen, P., Akslen, L., Armstrong, B., Avril, M., Azizi, E., Bakker, B., Bergman, W., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Cannon-Albright, L., Corda, E., Cust, A., Dębniak, T., Duffy, D., Dunning, A., Easton, D., Friedman, E., Galan, P., Ghiorzo, P., Giles, G., Hansson, J., Hocevar, M., Höiom, V., Hopper, J., Ingvar, C., Janssen, B., Jenkins, M., Jönsson, G., Kefford, R., Landi, G., Landi, M., Lang, J., Lubiński, J., Mackie, R., Malvehy, J., Martin, N., Molven, A., Montgomery, G., van Nieuwpoort, F., Novakovic, S., Olsson, H., Pastorino, L., Puig, S., Puig-Butille, J., Randerson-Moor, J., Snowden, H., Tuominen, R., Van Belle, P., van der Stoep, N., Whiteman, D., Zelenika, D., Han, J., Fang, S., Lee, J., Wei, Q., Lathrop, G., Gillanders, E., Brown, K., Goldstein, A., Kanetsky, P., Mann, G., Macgregor, S., Elder, D., Amos, C., Hayward, N., Gruis, N., Demenais, F., Bishop, J., Bishop, D. (2011), Genome-wide association study identifies three new melanoma susceptibility loci. Nature genetics. 43(11), 1108-13. [Abstract]
• Macgregor, S., Montgomery, G., Liu, J., Zhao, Z., Henders, A., Stark, M., Schmid, H., Holland, E., Duffy, D., Zhang, M., Painter, J., Nyholt, D., Maskiell, J., Jetann, J., Ferguson, M., Cust, A., Jenkins, M., Whiteman, D., Olsson, H., Puig, S., Bianchi-Scarrà, G., Hansson, J., Demenais, F., Landi, M., Dębniak, T., Mackie, R., Azizi, E., Bressac-de Paillerets, B., Goldstein, A., Kanetsky, P., Gruis, N., Elder, D., Newton-Bishop, J., Bishop, D., Iles, M., Helsing, P., Amos, C., Wei, Q., Wang, L., Lee, J., Qureshi, A., Kefford, R., Giles, G., Armstrong, B., Aitken, J., Han, J., Hopper, J., Trent, J., Brown, K., Martin, N., Mann, G., Hayward, N. (2011), Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nature Genetics. 43(11), 1114-1118. [Abstract]
• Schramm, S., Mann, G. (2011), Melanoma Prognosis: A REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies. Molecular cancer therapeutics. 10(8), 1520-8. [Abstract]
• Cust, A., Jenkins, M., Goumas, C., Armstrong, B., Schmid, H., Aitken, J., Giles, G., Kefford, R., Hopper, J., Mann, G. (2011), Early-life sun exposure and risk of melanoma before age 40 years. Cancer causes & control : CCC. 22(6), 885-97. [Abstract]
• Cust, A., Armstrong, B., Goumas, C., Jenkins, M., Schmid, H., Hopper, J., Kefford, R., Giles, G., Aitken, J., Mann, G. (2011), Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. International journal of cancer. Journal international du cancer. 128(10), 2425-35. [Abstract]
• Long, G., Menzies, A., Nagrial, A., Haydu, L., Hamilton, A., Mann, G., Hughes, T., Thompson, J., Scolyer, R., Kefford, R. (2011), Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma. Journal of Clinical Oncology. 29(10), 1239-1246. [Abstract]
• Cust, A., Harland, M., Makalic, E., Schmidt, D., Dowty, J., Aitken, J., Agha-Hamilton, C., Armstrong, B., Barrett, J., Chan, M., Chang, Y., Gascoyne, J., Giles, G., Holland, E., Kefford, R., Kukalizch, K., Lowery, J., Randerson-Moor, J., Schmid, H., Taylor, C., Whitaker, L., Hopper, J., Newton-Bishop, J., Mann, G., Bishop, D., Jenkins, M. (2011), Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK. Journal of medical genetics. 48(4), 266-72. [Abstract]
• Wakefield, C., Watts, K., Meiser, B., Sansom-Daly, U., Barratt, A., Mann, G., Lobb, E., Gaff, C., Howard, K., Patel, M. (2011), Development and pilot testing of an online screening decision aid for men with a family history of prostate cancer. Patient Education and Counseling. 83(1), 64-72. [Abstract]
• Hersey, P., Smalley, K., Weeraratna, A., Bosenberg, M., Zhang, X., Haass, N., Paton, E., Mann, G., Scolyer, R. (2011), Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010. Pigment Cell & Melanoma Research. 24(1), e1-e15. [Abstract]

2010

• Balleine, R., Provan, P., Pupo, G., Pathmanathan, N., Cummings, M., Farshid, G., Salisbury, E., Bilous, A., Byth, K., Mann, G. (2010), Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families. Genes, chromosomes & cancer. 49(12), 1082-94. [Abstract]
• Kasparian, N., McLoone, J., Meiser, B., Butow, P., Simpson, J., Mann, G. (2010), Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma. British journal of cancer. 103(10), 1502-9. [Abstract]
• Demenais, F., Mohamdi, H., Chaudru, V., Goldstein, A., Newton Bishop, J., Bishop, D., Kanetsky, P., Hayward, N., Gillanders, E., Elder, D., Avril, M., Azizi, E., van Belle, P., Bergman, W., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Carrera, C., Hansson, J., Harland, M., Hogg, D., Höiom, V., Holland, E., Ingvar, C., Landi, M., Lang, J., Mackie, R., Mann, G., Ming, M., Njauw, C., Olsson, H., Palmer, J., Pastorino, L., Puig, S., Randerson-Moor, J., Stark, M., Tsao, H., Tucker, M., van der Velden, P., Yang, X., Gruis, N. (2010), Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study. Journal of the National Cancer Institute. 102(20), 1568-83. [Abstract]
• Kaufman, K., Belov, L., Huang, P., Mactier, S., Scolyer, R., Mann, G., Christopherson, R. (2010), An extended antibody microarray for surface profiling metastatic melanoma. Journal of immunological methods. 358(1-2), 23-34. [Abstract]
• McKenzie, H., Fung, C., Becker, T., Irvine, M., Mann, G., Kefford, R., Rizos, H. (2010), Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A. Human mutation. 31(6), 692-701. [Abstract]
• Scurr, L., Pupo, G., Becker, T., Lai, K., Schrama, D., Haferkamp, S., Irvine, M., Scolyer, R., Mann, G., Becker, J., Kefford, R., Rizos, H. (2010), IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell. 141(4), 717-727. [Abstract]

2009

• Cust, A., Schmid, H., Maskiell, J., Jetann, J., Ferguson, M., Holland, E., Agha-Hamilton, C., Jenkins, M., Kelly, J., Kefford, R., Giles, G., Armstrong, B., Aitken, J., Hopper, J., Mann, G. (2009), Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study. American Journal of Epidemiology. 170(12), 1541-1554. [Abstract]
• Leachman, S., Carucci, J., Kohlmann, W., Banks, K., Asgari, M., Bergman, W., Bianchi-Scarrà, G., Brentnall, T., Bressac-de Paillerets, B., Bruno, W., Curiel-Lewandrowski, C., de Snoo, F., Debniak, T., Demierre, M., Elder, D., Goldstein, A., Grant-Kels, J., Halpern, A., Ingvar, C., Kefford, R., Lang, J., MacKie, R., Mann, G., Mueller, K., Newton-Bishop, J., Olsson, H., Petersen, G., Puig, S., Rigel, D., Swetter, S., Tucker, M., Yakobson, E., Zitelli, J., Tsao, H. (2009), Selection criteria for genetic assessment of patients with familial melanoma. Journal of the American Academy of Dermatology. 61(4), 677.e1-677.e14. [Abstract]
• Howard, K., Barratt, A., Mann, G., Patel, M. (2009), A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices. Archives of Internal Medicine. 169(17), 1603-1610. [Abstract]
• Bishop, D., Demenais, F., Iles, M., Harland, M., Taylor, J., Corda, E., Randerson-Moor, J., Aitken, J., Avril, M., Azizi, E., Bakker, B., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Cannon-Albright, L., Chin-A-Woeng, T., Debniak, T., Galore-Haskel, G., Ghiorzo, P., Gut, I., Hansson, J., Hocevar, M., Höiom, V., Hopper, J., Ingvar, C., Kanetsky, P., Kefford, R., Landi, M., Lang, J., Lubiński, J., Mackie, R., Malvehy, J., Mann, G., Martin, N., Montgomery, G., van Nieuwpoort, F., Novakovic, S., Olsson, H., Puig, S., Weiss, M., van Workum, W., Zelenika, D., Brown, K., Goldstein, A., Gillanders, E., Boland, A., Galan, P., Elder, D., Gruis, N., Hayward, N., Lathrop, G., Barrett, J., Bishop, J. (2009), Genome-wide association study identifies three loci associated with melanoma risk. Nature Genetics. 41(8), 920-925. [Abstract]
• Kasparian, N., Meiser, B., Butow, P., Simpson, J., Mann, G. (2009), Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genetics in Medicine. 11(4), 265-278. [Abstract]
• Scaini, M., Rossi, E., Torres, P., Zullato, D., Callegaro, M., Casella, C., Quaggio, M., Agata, S., Malacrida, S., Chiarion-Sileni, V., Vecchiato, A., Alaibac, M., Montagna, M., Mann, G., Menin, C., D'Andrea, E. (2009), Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 671(1-2), 26-32. [Abstract]
• Becker, T., Haferkamp, S., Dijkstra, M., Scurr, L., Frausto, M., Diefenbach, E., Scolyer, R., Reisman, D., Mann, G., Kefford, R., Rizos, H. (2009), The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Molecular Cancer. 8, 4. [Abstract]
• Morey, A., Murali, R., McCarthy, S., Mann, G., Scolyer, R. (2009), Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology. 41(4), 383-7. [Abstract]
• Gartside, M., Chen, H., Ibrahimi, O., Byron, S., Curtis, A., Wellens, C., Bengston, A., Yudt, L., Eliseenkova, A., Ma, J., Curtin, J., Hyder, P., Harper, U., Riedesel, E., Mann, G., Trent, J., Bastian, B., Meltzer, P., Mohammadi, M., Pollock, P. (2009), Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Molecular Cancer Research. 7(1), 41-54. [Abstract]

2008

• Gallagher, S., Thompson, J., Indsto, J., Scurr, L., Lett, M., Gao, B., Dunleavey, R., Mann, G., Kefford, R., Rizos, H. (2008), p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors. Neoplasia. 10(11), 1231-1239. [Abstract]
• Brown, K., Macgregor, S., Montgomery, G., Craig, D., Zhao, Z., Iyadurai, K., K Henders, A., Homer, N., Campbell, M., Stark, M., Thomas, S., Schmid, H., Holland, E., Gillanders, E., Duffy, D., Maskiell, J., Jetann, J., Ferguson, M., Stephan, D., Cust, A., Whiteman, D., Green, A., Olsson, H., Puig, S., Ghiorzo, P., Hansson, J., Demenais, F., Goldstein, A., Gruis, N., Elder, D., Bishop, J., Kefford, R., Giles, G., Armstrong, B., Aitken, J., Hopper, J., Martin, N., Trent, J., Mann, G., Hayward, N. (2008), Common sequence variants on 20q11.22 confer melanoma susceptibility. Nature genetics. 40(7), 838-40. [Abstract]
• Wakefield, C., Meiser, B., Gaff, C., Barratt, A., Patel, M., Suthers, G., Lobb, E., Ramsay, J., Mann, G. (2008), Issues Faced by Unaffected Men With a Family History of Prostate Cancer: A Multidisciplinary Overview. The Journal of urology. 180(1), 38-46; discussion 46. [Abstract]
• Harland, M., Goldstein, A., Kukalizch, K., Taylor, C., Hogg, D., Puig, S., Badenas, C., Gruis, N., ter Huurne, J., Bergman, W., Hayward, N., Stark, M., Tsao, H., Tucker, M., Landi, M., Scarra, G., Ghiorzo, P., Kanetsky, P., Elder, D., Mann, G., Holland, E., Bishop, D., Bishop, J. (2008), A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). European journal of cancer. 44(9), 1269-1274. [Abstract]
• Kasparian, N., Butow, P., Meiser, B., Mann, G. (2008), High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective. Psycho-oncology. 17(3), 270-9. [Abstract]
• Kasparian, N., Meiser, B., Butow, P., Simpson, J., Mann, G. (2008), Predictors of psychological distress among individuals with a strong family history of malignant melanoma. Clinical genetics. 73(2), 121-131. [Abstract]
• Wong, E., Tesoriero, A., Pupo, G., McCredie, M., Giles, G., Hopper, J., Mann, G., Goldgar, D., Southey, M. (2008), Is MSH2 a breast cancer susceptibility gene?. Familial cancer. 7(2), 151-155. [Abstract]

2007

• Marsh, A., Healey, S., Lewis, A., Spurdle, A., Kedda, M., Khanna, K., Mann, G., Pupo, G., Lakhani, S., Chenevix-Trench, G. (2007), Mutation analysis of five candidate genes in familial breast cancer. Breast Cancer Research and Treatment. 105(3), 377-389. [Abstract]
• Gurney, H., Wong, M., Balleine, R., Rivory, L., McLachlan, A., Hoskins, J., Wilcken, N., Clarke, C., Mann, G., Collins, M., Delforce, S., Lynch, K., Schran, H. (2007), Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype. Clinical Pharmacology and Therapeutics. 82(1), 33-40. [Abstract]
• Indsto, J., Kumar, S., Wang, L., Crotty, K., Arbuckle, S., Mann, G. (2007), Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions. Journal of Cutaneous Pathology. 34(6), 448-455. [Abstract]
• Goldstein, A., Chan, M., Harland, M., Hayward, N., Demenais, F., Bishop, D., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., Calista, D., Cannon-Albright, L., Chaudru, V., Chompret, A., Cuellar, F., Elder, D., Ghiorzo, P., Gillanders, E., Gruis, N., Hansson, J., Hogg, D., Holland, E., Kanetsky, P., Kefford, R., Landi, M., Lang, J., Leachman, S., Mackie, R., Magnusson, V., Mann, G., Newton-Bishop, J., Palmer, J., Puig, S., Puig-Butille, J., Stark, M., Tsao, H., Tucker, M., Whitaker, L., Yakobson, E., Study Group, L., Genomel, M. (2007), Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents. Journal of medical genetics. 44(2), 99-106. [Abstract]
• Kasparian, N., Meiser, B., Butow, P., Soames Job, R., Mann, G. (2007), Anticipated uptake of genetic testing for familial melanoma in an Australian sample: an exploratory study. Psycho-oncology. 16(1), 69-78. [Abstract]
• Lose, F., Arnold, J., Young, D., Brown, C., Mann, G., Pupo, G., Khanna, K., Chenevix-Trench, G., Spurdle, A. (2007), BCoR-L1 variation and breast cancer. Breast Cancer Research. 9(4), R54. [Abstract]